A Case of Nasopharyngeal Carcinoma with Metastatic Axillary Node after Concurrent Chemoradiotherapy |
Hong, Hyun-Jun
(Department of Otorhinolaryngology, National Health Insurance Corporation Ilsan Hospital)
Lee, Won-Il (Department of Otorhinolaryngology, National Health Insurance Corporation Ilsan Hospital) Park, Mi-Na (Department of Otorhinolaryngology, National Health Insurance Corporation Ilsan Hospital) Chung, Eun-Ji (Department of Radiation Oncology, National Health Insurance Corporation Ilsan Hospital) Kim, Yong-Tai (Internal Medicine, National Health Insurance Corporation Ilsan Hospital) Choi, Eun-Chang (Department of Otorhinolaryngology, Yonsei University College of Medicine) |
1 | Farias TP, Dias FL, Lima RA, Kliqerman J, de Sa GM, Barbosa MM, et al. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129(7): 794-799 DOI ScienceOn |
2 | Skinner DW, Van Hasselt CA, Tsao SY. Nasopharyngeal carinoma: Modes of presentation. Ann Otol Rhinol Laryngol. 1991;100(7):544-551 DOI PUBMED |
3 | Dubrulle F, Souillard R, Hermans R. Extension patterns of nasopharyngeal carcinoma. Eur Radiol. 2007;17:2622-2630 DOI ScienceOn |
4 | Dickson RI. Nasopharyngeal carcinoma: an evaluation of 209 patients. Laryngoscope. 1981;91(3):333-354 DOI PUBMED ScienceOn |
5 | Zhu XN, Chen R, Kong FH, Liu W. Human Leukocyte antigens-A,-B,-C and -DR and nasopharyngeal carcinoma in northern China. Ann Otol Rhinol Laryngol. 1990;99:286-287 DOI PUBMED |
6 | Wei WI. Contribution of the Otorhinolaryngologist to the Management of Nasopharyngeal Carcinoma. Korean J Otolaryngol.2002;45:311-317 |
7 | Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer. 2000;85(3):358-363 DOI ScienceOn |
8 | Vikram B, Strong EW, Manolatos S, Mishra UB. Improved survival in carcinoma of the nasopharynx. Head Neck Surg. 1984;7(2):123-128 DOI ScienceOn |
9 | Lee CM, Hayostek CJ, Abbott TM, Hathaway PB, Watson GA. Nasopharyngeal carcinoma with axillary node involvement as a component of failure following chemoradiotherapy. Ear Nose Throat J. 2005;84(3):159-160 PUBMED |
10 | Baek SJ, Lee SY, Lim YC, Koo BS, Lee JS, Lee CG, et al. Treatment Outcome, Prognostic Factors and Patterns of Failure of nasopharyngeal carcinoma. Korean J Otolaryngol. 2005;48:1254-1260 |
11 | Nakamura T, Kodaira T, Tachibana H, Tomita N, Tomoda T, Nakahara R, et al. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: Treatment outcome and prognostic factors. Japanease J Clin Oncol. 2008;38(12):803-9. Epub 2008 Oct 7 DOI ScienceOn |
12 | Ho JH. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1978;4(3-4):182-198 DOI PUBMED |